Sagittarius Life Science (3205) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.020x

Based on the latest financial reports, Sagittarius Life Science (3205) has a cash flow conversion efficiency ratio of -0.020x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-21.27 Million ≈ $-670.00K USD) by net assets (NT$1.04 Billion ≈ $32.92 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Sagittarius Life Science for the company's overall valuation and market capitalisation.

Sagittarius Life Science - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how Sagittarius Life Science's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Sagittarius Life Science Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sagittarius Life Science ranked by their cash flow conversion efficiency. Explore 3205 operating cash flow to net income to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Kino Polska TV SA WAR:KPL	0.081x
Kencana Agri Limited F:KEBA	0.269x
Industri Dan Perdagangan Bintraco Dharma Tbk PT JK:CARS	0.014x
Desa Deri Sanayi ve Ticaret AS IS:DESA	0.145x
ALi Corp TW:3041	-0.014x
STARPHARMA HLDG.SP.ADR/10 F:PQ6A	N/A
JEIO CO LTD (PROPOSED) KQ:418550	0.000x
Dharmaj Crop Guard Limited NSE:DHARMAJ	0.001x

Annual Cash Flow Conversion Efficiency for Sagittarius Life Science (2015–2025)

The table below shows the annual cash flow conversion efficiency of Sagittarius Life Science from 2015 to 2025. View today's stock price for Sagittarius Life Science for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	NT$1.04 Billion ≈ $32.92 Million	NT$-36.05 Million ≈ $-1.14 Million	-0.035x	+67.44%
2024-12-31	NT$419.76 Million ≈ $13.22 Million	NT$-44.48 Million ≈ $-1.40 Million	-0.106x	+19.51%
2023-12-31	NT$526.90 Million ≈ $16.60 Million	NT$-69.37 Million ≈ $-2.19 Million	-0.132x	-13.36%
2022-12-31	NT$455.42 Million ≈ $14.35 Million	NT$-52.89 Million ≈ $-1.67 Million	-0.116x	-111.62%
2021-12-31	NT$531.71 Million ≈ $16.75 Million	NT$-29.18 Million ≈ $-919.36K	-0.055x	+48.12%
2020-12-31	NT$588.38 Million ≈ $18.54 Million	NT$-62.24 Million ≈ $-1.96 Million	-0.106x	+31.72%
2019-12-31	NT$674.50 Million ≈ $21.25 Million	NT$-104.50 Million ≈ $-3.29 Million	-0.155x	-113.51%
2018-12-31	NT$797.37 Million ≈ $25.12 Million	NT$-57.86 Million ≈ $-1.82 Million	-0.073x	-200.52%
2017-12-31	NT$965.47 Million ≈ $30.42 Million	NT$-23.31 Million ≈ $-734.49K	-0.024x	-108.12%
2016-12-31	NT$1.21 Billion ≈ $38.18 Million	NT$360.37 Million ≈ $11.35 Million	0.297x	-10.68%
2015-12-31	NT$714.71 Million ≈ $22.52 Million	NT$237.94 Million ≈ $7.50 Million	0.333x	--

About Sagittarius Life Science

TWO:3205 Taiwan Biotechnology

Market Cap

$99.27 Million

NT$3.15 Billion TWD

Market Cap Rank

#19313 Global

#1082 in Taiwan

Share Price

NT$46.65

Change (1 day)

+0.76%

52-Week Range

NT$43.95 - NT$62.50

All Time High

NT$289.67